Trxade Group Inc. MEDS Archives - Page 8 of 9

ThursdayMar 26, 2020 10:55 am

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Subsidiary Bonum Health Offers Virtual Care Solution During Nationwide Crisis

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform has developed an affordable safety-first healthcare option for the 27.5 million uninsured Americans through its virtual care platform. This cost-effective option may also serve as a solution for many Americans who struggle with large provider visit deductibles and copays. Bonum Health's telehealth platform has proven to be a safe and effective option for connecting patients and providers with the rapid spread of the Coronavirus (COVID-19) in the United States. Warnings of a 14-day incubation period of the Coronavirus symptoms have put the general public on edge, and…

FridayMar 20, 2020 11:13 am

Trxade Group Inc. (NASDAQ: MEDS) Has Over 11,900 Pharmacies on Trading Platform, with No Contract or Fee Obligations

Major first-mover advantage in proprietary web-based e-commerce platform segment Penetrating U.S. independent pharmacy market with total purchases of $92 billion per annum Adding 100+ pharmacies per month to its online purchasing platform Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and health care platform that offers health care buyers and sellers of pharmaceuticals procurement, currently has more than 11,900 pharmacies as registered users of its proprietary e-commerce platform. Registered users are under no contract of fee obligations when joining the ‘Supplier-to-Pharmacy’ (S2P) trading platform. With the current number of users already on the network – serving an estimated…

ThursdayMar 19, 2020 12:54 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Heightens Visibility via Nasdaq Listing

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, recently announced its uplisting to the Nasdaq Capital Market and rang the opening bell on Friday, Feb. 28, 2020. An article discussing the company reads, “‘We’ve been under the radar for a long time. We’re trying to create visibility among the investor base by doing the right thing,’ CEO Suren Ajjarapu stated late last year following completion of an agreement between its subsidiary Bonum Health and Benzer Pharmacy to create a network of ‘Bonum Health Hub’ units in small towns and rural areas as part of the lead-up to…

WednesdayMar 11, 2020 1:52 pm

Trxade Group Inc. (NASDAQ: MEDS) Subsidiaries’ Visionary Telehealth Services Help Limit Impact of Global Viruses

Pioneering supplier-to-pharmacy tech platform builder Trxade Group Inc. helps small, community-based pharmaceutical businesses be competitive with larger chains by sourcing drugs at discount prices and promoting transparency in business operations Trxade Group has been developing its subscribers’ access to licensed medical professionals through telehealth services that are both convenient to the patient and significant in their ability to limit the number of people visiting hospitals and offices Amid the sweeping, deadly impact of the seasonal flu and the rising novel coronavirus epidemic, Trxade’s online access to physicians is a timely preventative service Trxade Group Inc. recently announced its uplisting to…

TuesdayMar 10, 2020 9:51 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly subscription rate of $19.95 now includes an option of three (3) premium visits per month as well as free prescription delivery service through its subsidiaries. A virtual healthcare subsidiary, Bonum Health provides telehealth services and prescription ordering via teleconferences that are routinely conducted using smart devices. The company provides a HIPPA compliant, dynamic way for patients to access board-certified physicians from the comfort of their…

FridayMar 06, 2020 10:52 am

Trxade Group Inc. (NASDAQ: MEDS) Captures Significant Independent Pharmacy Market Share and Continues Steady Growth in 2020

Trxade Group has captured nearly half of the independent pharmacy market with its web-based purchasing platform “E-Bay/Kayak-like” Supplier-to-Pharmacy trading platform improves transaction processing between independent pharmacists and drug distributors Predictive data analytics features, price visibility and profit optimization within the platform are critical as the general population ages Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors; a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings…

ThursdayMar 05, 2020 11:15 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Exhibit at HIMSS 2020 Global Health Conference & Exhibition

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020. The event, which will draw over 45,000 healthcare professionals, is slated to take place at the Orange County Convention center in Orlando, Florida from March 9-13. Trxade’s booth will be located in Exhibit Hall E, Booth (#7273), Kiosk (#13). Members from the company’s leadership team will be present and provide detailed DEMO and information on products including: DelivMeds and Bonum Health, demonstrating the latest advances…

FridayFeb 28, 2020 9:00 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) CEO Rings Nasdaq Opening Bell

Trxade Group (NASDAQ: MEDS) announced that the company’s chief executive officer Suren Ajjarapu will ring the Nasdaq opening bell at 9:30 AM ET on February 28, 2020, signifying the start of trade. Trxade Group is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals. The company’s common stock began trading on the Nasdaq Capital Market under its new symbol ‘MEDS’ on February 13, 2020. To view the full press release, visit http://ibn.fm/fCKGu About Trxade Group, Inc. Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is…

MondayFeb 24, 2020 10:50 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced firm commitment underwritten offering which closed on February 18, 2020. According to the update, the exercise of the overallotment option and the underwriters purchase of 115,767 shares of common stock, each at the public offering price of $6.50, less the underwriters’ discount of $0.52 per share, resulted in net pricing of $5.98 per share. Trxade Group received approximately $0.7 million…

WednesdayFeb 19, 2020 10:43 am

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and healthcare platform that offers healthcare buyers and sellers of pharmaceuticals increased profit margins, announced that its common stock has begun trading on the Nasdaq Capital Market under new ticker symbol ‘MEDS’, as of February 13, 2020. The company’s common stock will cease trading…

Site Search

Company Search

Tag: Trxade Group Inc. MEDS